Liraglutide reduces lipogenetic signals in visceral adipose of db/db mice with AMPK activation and Akt suppression

Liraglutide, a glucagon-like peptide-1 analog, has been proved to reduce body weight and visceral adipose tissue (VAT) in human studies. In this study, we aimed at examining lipogenetic signal changes in VAT after weight-loss with liraglutide in db/db mice. The mice were divided into two groups: lir...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Yimin, Yuan, Geheng, Zhang, Junqing, Guo, Xiaohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342181/
https://www.ncbi.nlm.nih.gov/pubmed/25733821
http://dx.doi.org/10.2147/DDDT.S79175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342181/
https://www.ncbi.nlm.nih.gov/pubmed/25733821
http://dx.doi.org/10.2147/DDDT.S79175

Ejemplares similares